This organization functions as a contract research organization (CRO), providing outsourced pharmaceutical development and clinical trial services to the biotechnology and pharmaceutical industries. Its core business revolves around supporting drug development from early-phase studies to post-approval commercialization.
The activities of this entity are vital to the advancement of new therapies and treatments. By offering expertise in clinical research, data management, and regulatory affairs, it enables pharmaceutical companies to accelerate their drug development timelines and bring innovative medicines to market more efficiently. The company’s history reflects the evolving landscape of drug development outsourcing and its growing significance in the healthcare sector.